L'hôpital de la Timone est le plus grand hôpital de Marseille. Les bâtiments actuels datent de 1973 mais se trouvent sur le site d'un ancien hôpital. L'hôpital appartient à l'Assistance publique - Hôpitaux de Marseille. Il est aussi le siège du Service d'aide médicale urgente et du 15 de Marseille.

During the past decade, Hopital de la Timone conducted 421 clinical trials. In the 10-year time frame, 421 clinical trials started and 96 clinical trials were completed, i.e. on average, 22.8% percent of trials that started reached the finish line to date. In the past 5 years, 205 clinical trials started and 70 clinical trials were completed. i.e. 34.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital de la Timone" #1 sponsor was "UNICANCER" with 33 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 23 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 23 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 20 trials sponsored and "Hoffmann-La Roche" with 20 trials sponsored. Other sponsors include 522 different institutions and companies that sponsored additional 226 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital de la Timone" #1 collaborator was "Ministry of Health, France" with 19 trials as a collaborator, "National Cancer Institute, France" with 12 trials as a collaborator, "Bristol-Myers Squibb" with 7 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 7 trials as a collaborator and "AstraZeneca" with 6 trials as a collaborator. Other collaborators include 303 different institutions and companies that were collaborators in the rest 218 trials.

According to Clinical.Site data, the most researched conditions in "Hopital de la Timone" are "Amyotrophic Lateral Sclerosis" (12 trials), "Melanoma" (11 trials), "Sarcoma" (11 trials), "Alzheimer Disease" (10 trials) and "Colorectal Cancer" (10 trials). Many other conditions were trialed in "Hopital de la Timone" in a lesser frequency.

Most popular intervention types in "Hopital de la Timone" are "Drug" (403 trials), "Device" (83 trials), "Other" (81 trials), "Procedure" (55 trials) and "Biological" (45 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (78 trials), "radiation therapy" (15 trials), "Gemcitabine" (13 trials), "Nivolumab" (13 trials) and "Carboplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "Hopital de la Timone" are 604 trials for "All" genders, 21 trials for "Male" genders and 19 trials for "Female" genders.

Currently, there are 241 active trials in "Hopital de la Timone". 7 are not yet recruiting, 161 are recruiting, 72 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 299 completed trials in Hopital de la Timone, undefined suspended trials, and 58 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital de la Timone, 65 "Phase 1" clinical trials were conducted, 195 "Phase 2" clinical trials and 193 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 90 trials that are defined as “Not Applicable".